Detailed price information for Fate Therapeutics (FATE-Q) from The Globe and Mail including charting and trades.

NovelStem International Corp., a development stage biotechnology holding company, focuses on development and commercialization of stem cell-based diagnostic technology for cancer treatments and to ...

In a history-making exercise, the Fudan University in Shanghai (China) not only broke a previously held record but managed to ...

High-throughput screening (HTS) enables the rapid testing of numerous compounds against biological targets. By automating and ...

An RNA-editing gene therapy has been developed that switches off the key driver of common eye conditions affecting diabetics ...

The meeting brought together doctors and scientists to explore cutting-edge healthcare technologies. Organised by the AAHII ...

Another important development collaboration we have is with the Connect ... as well as a lack of curative therapies other ...

The devastated family of a "one in a million" young man who died after being struck by a car have paid an emotional tribute ...

A Michigan State University researcher's new model for studying breast cancer could help scientists better understand why and ...

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) – Research analysts at HC Wainwright reduced their FY2024 earnings ...